Consolidated Balance Sheets (USD $) In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Current Assets
Cash and cash equivalents (variable interest entities restricted - 2014: $190; 2013: $147)	$ 5,654	$ 5,940
Accounts and notes receivable:
Trade (net of allowance for doubtful receivables - 2014: $110; 2013: $148)	4,685	4,935
Other	4,687	4,712
Inventories	8,101	8,303
Deferred income tax assets - current	812	743
Other current assets	328	344
Total current assets	24,267	24,977
Investments
Investment in nonconsolidated affiliates	4,201	4,501
Other investments (investments carried at fair value - 2014: $2,009; 2013: $2,056)	2,439	2,541
Noncurrent receivables	620	365
Total investments	7,260	7,407
Property
Property	55,230	55,114
Less accumulated depreciation	37,179	37,660
Net property (variable interest entities restricted - 2014: $2,726; 2013: $2,646)	18,051	17,454
Other Assets
Goodwill	12,632	12,798
Other intangible assets (net of accumulated amortization - 2014: $3,737; 2013: $3,270)	3,768	4,314
Deferred income tax assets - noncurrent	2,135	1,964
Asbestos-related insurance receivables - noncurrent	62	86
Deferred charges and other assets	621	501
Total other assets	19,218	19,663
Total Assets	68,796	69,501
Current Liabilities
Notes payable	551	443
Long-term debt due within one year	394	697
Accounts payable:
Trade	4,481	4,590
Other	2,299	2,290
Income taxes payable	361	435
Deferred income tax liabilities - current	105	133
Dividends payable	563	467
Accrued and other current liabilities	2,839	2,916
Total current liabilities	11,593	11,971
Long-Term Debt (variable interest entities nonrecourse - 2014: $1,229; 2013: $1,360)	18,838	16,820
Other Noncurrent Liabilities
Deferred income tax liabilities - noncurrent	622	718
Pension and other postretirement benefits - noncurrent	10,459	8,176
Asbestos-related liabilities - noncurrent	438	434
Other noncurrent obligations	3,290	3,302
Total other noncurrent liabilities	14,809	12,630
Redeemable Noncontrolling Interest	202	156
Stockholders' Equity
Preferred stock, series A ($1.00 par, $1,000 liquidation preference, 4,000,000 shares)	4,000	4,000
Common stock (authorized 1,500,000,000 shares of $2.50 par value each;issued 2014: 1,242,763,276 shares; 2013: 1,221,557,253 shares)	3,107	3,054
Additional paid-in capital	4,846	3,928
Retained earnings	23,045	21,407
Accumulated other comprehensive loss	(8,017)	(4,827)
Unearned ESOP shares	(325)	(357)
Treasury stock at cost (2014: 85,168,571 shares; 2013: 8,152,030 shares)	(4,233)	(307)
The Dow Chemical Company's stockholders' equity	22,423	26,898
Non-redeemable noncontrolling interests	931	1,026
Total equity	23,354	27,924
Total Liabilities and Equity	$ 68,796	$ 69,501